Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
805K
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
27
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$5.00
-
Value change
-
-$266K
-
Number of sells
-
-11
-
Price
-
$0.19
Significant Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q4 2024
12 filings reported holding INM - InMed Pharmaceuticals Inc. - Common Shares, no par value as of Q4 2024.
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27 shares
of 805K outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Global Retirement Partners, LLC (0 shares), Baader Bank Aktiengesellschaft (0 shares), AllSquare Wealth Management LLC (0 shares), Virtu Financial LLC (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), Federation des caisses Desjardins du Quebec (0 shares), UBS Group AG (0 shares), HRT FINANCIAL LP (0 shares), CITADEL ADVISORS LLC (0 shares), and AdvisorShares Investments LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.